Behavioral
Brain & Spine Medical Services PLLC
Brain & Spine Medical Services PLLC was paid $800K by Medicaid between Jan 2018 and Nov 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoBRAIN & SPINE MEDICAL SERVICES PLLC
WILLIAMSVILLE, NY 14221
WILLIAMSVILLE, NY 14221
33aNPI1073631644assigned 03/26/2007
33bProvider typePsychologist
28Total paid$800K
24GClaims17,487
24DCodes billed41
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Psychologist providers in New York
Rank by total paid#28 of 255
Median peer was paid$39K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,869 | $135K | |
| 2019 | 1,822 | $97K | |
| 2020 | 2,441 | $106K | |
| 2021 | 3,476 | $121K | |
| 2022 | 3,147 | $129K | |
| 2023 | 2,926 | $139K | |
| 2024incomplete | 806 | $73K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 7,502 | 7,302 | $455K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 4,538 | 4,372 | $194K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5.3% | 584 | 582 | $42K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.2% | 402 | 392 | $41K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.6% | 120 | 120 | $13K |
| 59426 | 1.3% | 41 | 34 | $10K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 103 | 103 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 244 | 242 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 395 | 390 | $6K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 51 | 51 | $5K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | 13 | $4K |
| 72110 | <1% | 78 | 78 | $3K |
29 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 89 | $2K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 510 | $2K |
| 96139 | <1% | 22 | $2K | |
| 90674 | <1% | 52 | $2K | |
| 96132 | <1% | 12 | $1K | |
| 99442 | <1% | 18 | $508.02 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 54 | $429.75 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $395.46 |
| 96136 | <1% | 14 | $387.05 | |
| 72050 | <1% | 12 | $385.84 | |
| 96138 | <1% | 12 | $257.40 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 12 | $249.04 |
| 80305 | <1% | 36 | $187.40 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $158.51 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 15 | $106.03 |
| 3079F | <1% | 373 | $60.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 84 | $42.77 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $41.58 |
| 36415 | Collection of venous blood by venipuncture | <1% | 26 | $32.25 |
| 3074F | <1% | 491 | $20.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 13 | $0.13 |
| 3077F | 0% | 81 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 634 | $0.00 |
| 99080 | 0% | 263 | $0.00 | |
| 3078F | 0% | 105 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 371 | $0.00 |
| 3080F | 0% | 35 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 29 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANDI, MICHAEL (CEO)
| Provider | Location | Paid |
|---|---|---|
| Reliant Pharmacy Corp | Buffalo, NY | $1.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.